Oct 5, 2026 07:01AM
Oct 5, 2026 07:00AM
Oct 2, 2026 06:04AM
Oct 2, 2026 02:30AM
Sep 28, 2026 05:33PM
Sep 28, 2026 05:30PM
Sep 22, 2026 06:01AM Ivonescimab trial data in biliary tract cancer to be shown at ESMO 2026
Sep 22, 2026 06:00AM
Sep 15, 2026 06:01AM
Sep 15, 2026 06:00AM
Sep 13, 2026 07:47PM
Sep 13, 2026 07:00AM
Aug 25, 2026 06:39PM
Aug 25, 2026 06:00PM Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Tria
Aug 25, 2026 07:02AM
Aug 25, 2026 07:00AM
Aug 12, 2026 09:22AM
Aug 12, 2026 09:22AM
Aug 5, 2026 07:00AM
Jul 23, 2026 04:06PM
Jul 23, 2026 04:05PM Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026
Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Jul 22, 2026 06:30AM
Jul 22, 2026 06:30AM
Jul 16, 2026 08:00AM
Jul 14, 2026 07:00AM
Jul 14, 2026 07:00AM Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.
Jun 4, 2026 04:30PM
Jun 1, 2026 02:53AM
May 31, 2026 09:06AM
May 30, 2026 08:00AM
Apr 30, 2026 04:32PM
Mar 27, 2026 08:16AM
Mar 27, 2026 08:15AM Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
Feb 26, 2026 06:45PM
Feb 23, 2026 04:05PM
Feb 17, 2026 05:05PM
Jan 30, 2026 04:30PM
Jan 29, 2026 07:30AM
Jan 29, 2026 07:30AM
Jan 12, 2026 06:15AM Summit Therapeutics partners with GSK for cancer drug combination trial
Jan 12, 2026 06:15AM
Jan 12, 2026 06:01AM
Jan 12, 2026 06:00AM
Jan 9, 2026 08:16PM
Jan 6, 2026 07:30AM
Dec 5, 2025 04:30PM
Nov 7, 2025 09:02AM Ivonescimab shows survival benefit in lung cancer study
Nov 7, 2025 09:00AM

13,444 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All